Utility of social media and crowd-intelligence data for pharmacovigilance: a scoping review https://t.co/0gu6T9b3yv #twitterx
@LeoCaravagna @Adel__Mebarki @Keyrus_group @GFaghe @eVeDrugClaude @MeCarolineHenry @Kap_Code @Epiconcept @TICpharma A l'échelle européenne les travaux du consortium IMI Web-RADR @WEBRADR , dernière publication https://t.co/oSPWFAO5cD ou https://t.co/1UIeQS
RT @KTCanada: Newly published article from the #KnowledgeSynthesis team in the KT Program in Toronto - "Utility of social media and crowd-i…
RT @KTCanada: Newly published article from the #KnowledgeSynthesis team in the KT Program in Toronto - "Utility of social media and crowd-i…
RT @KTCanada: Newly published article from the #KnowledgeSynthesis team in the KT Program in Toronto - "Utility of social media and crowd-i…
RT @KTCanada: Newly published article from the #KnowledgeSynthesis team in the KT Program in Toronto - "Utility of social media and crowd-i…
Pharmacovigilence using social media - an important piece of monitoring for drug adverse events https://t.co/E7cFc3gq3a
Newly published article from the #KnowledgeSynthesis team in the KT Program in Toronto - "Utility of social media and crowd-intelligence data for #pharmacovigilance: a scoping review." Well done, everyone! #KST #KTP @ATricco https://t.co/9s4RNu0z1C